pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Preclinical
TH-3215
Solid Tumor
$CNTNCanton Strategic Holdings, Inc.
0 catalysts
THALLOUS CHLORIDE TL 201
THALLOUS CHLORIDE TL 201 (THALLOUS CHLORIDE, TL 201)
CURIUM
0 catalysts
THIAMINE HYDROCHLORIDE
THIAMINE HYDROCHLORIDE (THIAMINE HYDROCHLORIDE)
SAGENT PHARMS INC
0 catalysts
Phase 3
THRV-1268
Arrhythmias
$THRYThryv Holdings, Inc.
← prev
page 140 of 231
next →
131
Pain89
Neurology1
0 catalysts
Phase 2
TILT-123
Ovarian Cancer
TILT Biotherapeutics Ltd
0 catalysts
TIMOLOL HEMIHYDRATE
TIMOLOL HEMIHYDRATE (TIMOLOL HEMIHYDRATE)
SOMERSET THERAPS LLC
0 catalysts
TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION
TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION (TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION)
GLAND
0 catalysts
TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION, 0.25%
TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION, 0.25% (TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION, 0.25%)
ALEMBIC
0 catalysts
TIROFIBAN
TIROFIBAN (TIROFIBAN)
EUGIA PHARMA
0 catalysts
TISSUEBLUE
TISSUEBLUE (BRILLIANT BLUE G)
DUTCH OPHTHALMIC
0 catalysts
Phase 1
TIX-100
Type 1 Diabetes (Juvenile Diabetes)
Tiximed Inc
0 catalysts
Preclinical
TJ-106
Breast Cancer
Phrontline Biopharma Co Ltd
0 catalysts
Preclinical
TLC-1235
Insulin Resistance
OrsoBio Inc
0 catalysts
pre_registration
TLD-002
Unspecified Metabolic Disorders
Tilde Sciences LLC
0 catalysts
Phase 2
TLD-1433
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Theralase Technologies Inc
0 catalysts
Phase 2
TLL-018
Plaque Psoriasis (Psoriasis Vulgaris)
Hangzhou Highlightll Pharmaceutical Co Ltd
0 catalysts
Phase 3
TLL-041
Parkinson's Disease
$BHVNBiohaven Ltd.
0 catalysts
Phase 2
TLP-02
Metablok
Acute Respiratory Distress Syndrome
Arch Biopartners Inc
0 catalysts
Phase 1
TLX-090
Cyclosam
Bone Metastasis
$TLXTelix Pharmaceuticals Ltd
0 catalysts
Preclinical
TLX-102
Malignant Glioma
$TLXTelix Pharmaceuticals Ltd
0 catalysts
Phase 2
TLX-250
Metastatic Renal Cell Carcinoma
$TLXTelix Pharmaceuticals Ltd
0 catalysts
Phase 1
TLY-012
Chronic Pancreatitis
D&D Pharmatech Co Ltd
0 catalysts
Phase 2
TMB-365
Human Immunodeficiency Virus (HIV) Infections (AIDS)
TaiMed Biologics Inc
0 catalysts
Phase 2
TMB-365 + TMB-380
Human Immunodeficiency Virus (HIV) Infections (AIDS)
TaiMed Biologics Inc
0 catalysts
Phase 1
TML-6
Alzheimer's Disease
Merry Life Biomedical Co Ltd
0 catalysts
Phase 2
TN-201
Hypertrophic Cardiomyopathy
$TNYATenaya Therapeutics, Inc.
0 catalysts
Phase 1
TN-301
Diastolic Heart Failure (HFpEF)
$TNYATenaya Therapeutics, Inc.
0 catalysts
Phase 2
TN-401
Cardiomyopathy
$TNYATenaya Therapeutics, Inc.
0 catalysts
Phase 2
TNG-260
Cervical Cancer
$TNGXTango Therapeutics, Inc.
0 catalysts
Phase 2
TNG-456
Bladder Cancer
$TNGXTango Therapeutics, Inc.
0 catalysts